Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs. (26th October 2020) - Wu, Jun; Zhou, Xing; Tan, Yuanqing; Wang, Liu; Li, Tianda; Li, Zhongwen; Gao, Tingting; Fan, Jiaqi; Guo, Baojie; Li, Wei; Hao, Jie; Wang, Xianguang; et al.